Vivanza Biosciences Limited (BOM:530057)

Vivanza Biosciences Revenue

In the fiscal year ending March 31, 2026, Vivanza Biosciences had annual revenue of 1.16B INR with 1,452.84% growth. Vivanza Biosciences had revenue of 63.72M in the quarter ending March 31, 2026, with 1,135.27% growth.

• Revenue: 1.16B
• Revenue Growth: +1,452.84%
• P/S Ratio: 0.06
• Revenue / Employee: 145.03M
• Employees: 8
• Market Cap: 74.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.16B	1.09B	1,452.84%
Mar 31, 2025	74.72M	-204.18M	-73.21%
Mar 31, 2024	278.89M	97.35M	53.62%
Mar 31, 2023	181.54M	69.55M	62.10%
Mar 31, 2022	111.99M	12.60M	12.67%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error